Sericin is a silk protein woven from silkworm cocoons (Bombyx mori). In animal model, sericin has been reported to have anti-tumoral action against colon cancer. The mechanisms underlying the activity of sericin against cancer cells are not fully understood. The present study investigated the effects of sericin on human colorectal cancer SW480 cells compared to normal colonic mucosal FHC cells. Since the size of the sericin protein may be important for its activity, two ranges of molecular weight were tested. Sericin was found to decrease SW480 and FHC cell viability. The small sericin had higher anti-proliferative effects than that of the large sericin in both cell types. Increased apoptosis of SW480 cells is associated with increased caspase-3 activity and decreased Bcl-2 expression. The anti-proliferative effect of sericin was accompanied by cell cycle arrest at the S phase. Thus, sericin reduced SW480 cell viability by inducing cell apoptosis via caspase-3 activation and down-regulation of Bcl-2 expression. The present study provides scientifi c data that support the protective effect of silk sericin against cancer cells of the colon and suggests that this protein may have signifi cant health benefi ts and could potentially be developed as a dietary supplement for colon cancer prevention.
INTRODUCTION
Colon cancer is one of the most common that causes cancer related deaths worldwide. The incidence is high, especially in developed countries, and it is now rising in developing countries like Thailand (Labianca et al., 2004; Khuhaprema and Srivatanakul, 2008) . Genetics, environment, lifestyle, and diet are considered important factors that contribute to the development of colon cancer. Epidemiological studies have indicated that diet signifi cantly infl uences the risk of colon cancer. Western dietary habits, especially high consumption of fat and red meat, increase risk of colon cancer, whereas high consumption of fruits, vegetables, and dietary fi bers probably protect against it (van Breda et al., 2008) . Because diet is an important factor for identifying risk of colon cancer, it is believed that 90% of colon cancer cases could be prevented by dietary intervention or by supplementary diets that protect against colon cancer (Johnson, 2004) .
Numerous studies in different experimental systems have shown that fruits and vegetables exert benefi cial effects through various mechanisms. The protective effects of fruits and vegetables to reduce colon cancer risk might be the result of their high content of anti-oxidant vitamins and fibers (Campos et al., 2005; Levi et al., 2001; Wogan, 1985) . Apart from fruits and vegetables, dietary proteins such as soy, whey, and buckwheat proteins have also been found to reduce the development of colon cancer in animals (Belobrajdic et al., 2003; Hakkak et al., 2001; Liu et al., 2001) . Interestingly, a nondietary protein called sericin has been reported to suppress colon tumorigenesis in both mice and rats (Zhaorigetu et al., 2001; Zhaorigetu et al., 2007) .
Sericin, a silk protein, is one of the main constituents of silk cocoons, comprising 20-30% of total cocoon weight (Sasaki et al., 2000) . Sericin is insoluble in cold water although it is easily dispersed or solubilised in hot water. Sericin is specifi cally synthesized in the middle gland of the silk worm, Bombyx mori. Sericin was found to suppress lipid peroxidation and tyrosinase inhibitory activity in an in vitro study (Kato et al., 1998) . Interestingly, it is resistant to several proteases, which might make sericin beneficial for colon health (Sasaki et al., 2000; Kato and Iwami, 2002) . Moreover, because of its proteinous nature, sericin is a biocompatible and biodegradable material. In addition to its anti-oxidant activity (Fan et al., 2009) , sericin exhibits chemopreventive effects by suppressing 7,12-dimethylbenze(a)anthracene/12-O-tetradecanoyl-phorbol-13-acetate(DMBA-TPA)-induced mouse skin tumorigenesis (Zhaorigetu et al., 2003) and colon tumorigenesis in 1,2-dimethylhydrazine (DMH)-induced colon cancer in animal models (Zhaorigetu et al., 2001; Zhaorigetu et al., 2007) . The mechanisms of its chemoprevention are associated with its ability to reduce colonic oxidative stress and colonic cell proliferation, and also to suppress aberrant crypt foci in animals (Zhaorigetu et al., 2001; Zhaorigetu et al., 2007) .
It should be noted that sericin preparation from silk cocoons is generally heterogeneous, with various sizes of polypeptides. Since sericin is a polymeric protein, different extraction techniques can provide different sizes or molecular weights of polypeptides consequently, exhibiting different effects (Terada et al., 2005) . Thus, the size of sericin appears to be important for its activity. For this reason, the present study investigated the effect of two differently sized sericin preparations on the viability of colonic cell lines, including cancerous cells SW480 and normal cells FHC. The effect of sericin on the cell cycle and apoptosis of these cells were investigated. Certain apoptotic cellular pathways involving caspase-3 activity as well as Bcl-2 and Bax protein expression were also investigated.
METHODS

Preparation of Sericin
Silk sericin was supplied by the Institution of Agricultural Technology, Suranaree University of Technology, Nakorn Ratchasrima, Thailand. The sericin was classifi ed into 2 types according to isolation techniques; large-size sericin (MW 191-339 kDa) and small-size sericin (MW 61-132 kDa). Briefl y, silk sericin was extracted with deionized water from raw silk yarns of the silkworm Bombyx mori under high pressure and high temperature. The specifi c extraction condition was under a pending Thai patent (application number 080595). The extract was later dried at 130 º C, and then ground and sieved through a 0.75 mm screen. The resulting sericin powder was sealed in sterile plastic bags and kept at room temperature until used. The sericin was used by reconstituting it in phosphate-buffered saline (PBS) and was sterilized by autoclaving at 121°C for 15 minutes.
Cell culture
The human colorectal cancer cells (SW480: ATCC number CCL-228) and normal human fetal colonic mucosal cells (FHC: ATCC number CRL-1831) were purchased from the American Type Culture Collection (ATCC: Manassas, VA, USA). The SW480 cells were cultured in Dulbecco's modifi ed Eagle's medium with HamF-12 (DMEM/F-12), supplemented with 10% fetal bovine serum (FBS) and 100 units/ml penicillin and 100 mg/ml streptomycin, all procured from Gibco, NY, USA. FHC cells were cultured in the above medium, supplemented with 25mM N'-2-Hydroxyethylpiperazine-N'-2 ethanesulphonic acid (HEPES) (JRH Biosciences, KS, USA), 5 mg/ml insulin (Sigma, MO, USA), and 100 ng/ml hydrocortisone (Sigma). Both SW480 and FHC cells were cultured in a humidifi ed atmosphere of 95% air and 5% CO 2 at 37 °C .
Cell viability assay
The cells were plated in 96-well plates at a concentration of 1 ´ 10 4 cells per well with complete culture medium. After an overnight incubation, the cells were exposed to various concentrations (25-1,600 mg/ml) of each type of sericin for 24, 48 and 72 h. MTT solution (0.5 mg/ml) was added to the culture medium 2 h before the end of the treatment period. Formazan crystals were then lysed with DMSO:ethanol (1:1), and the absorbance was read at 595 nm using a micro-plate reader (Beckman Coulter, NSW, Australia).
Cell apoptosis assay
Apoptosis was detected with an annexin V-FITC kit (Becton Dickinson, NJ, USA) according to the manufacturer's instructions. Initially, the cells were plated in a 60-mm culture dish at a concentration of 1´10 6 cells per dish with complete culture medium. After an overnight incubation, the cells were treated with sericin at a concentration of 1600 mg/ml for 72 h. After treatment, the cells were collected, washed with icecold phosphate-buffered saline (PBS) pH 7.4, centrifuged, and resuspended in 1X binding buffer. Cells were then stained with annexin V-FITC and propidium iodide (PI) solution, incubated for 15 min in the dark, and analyzed by FACSCalibur using CellQuestPro software (Becton Dickinson).
Caspase-3 activity assay
The cells were plated in 60-mm culture dishes at a concentration of 1´10 6 cells per dish with DMEM/F-12 with 10% FBS. After overnight incubation, the culture medium was replaced with a new complete medium and then treated with sericin at a concentration of 1600 mg/ml for 72 h. Then, the cells were harvested by trypsinization before caspase-3 activity was detected by using Caspase-3 fl uorimetric kit (Sigma). According to the manufacturer's instructions, caspase-3 activity was detected by using acetyl-Asp-Glu-Val-Asp-7-amido-4-methylcoumarin (Ac-DEVD-AMC) as a substrate. The fl uorescence of 7-amido-4-me thylcoumarin (AMC) was measured at Ex 360 nm and Em 460 nm.
Western blot analysis
The cells were plated in 60-mm culture dishes at a concentration of 1´10 6 cells per dish with DMEM/F-12 with 10% FBS. After overnight incubation, the culture medium was replaced with new complete medium and then treated with sericin at a concentration of 1600 mg/ml for 72 h. After treatment, the cells were lysed and the protein concentrations in cell lysate were determined by using a BCA protein assay kit (Thermo scientifi c, Rockford, USA). Twenty micrograms of each cell lysate sample were loaded and separated on SDSpolyacrylamide gel electrophoresis (SDS-PAGE). The resulting electrophoresis products were transferred onto a PVDF membrane and were then incubated with specifi c antibodies against Bcl-2 or Bax and then a secondary antibody conjugated with alkaline phosphatase. The protein bands were detected by using nitro blue tetrazolium chloride/5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP) as a substrate.
Cell cycle analysis
The cells were plated in 60-mm culture dishes at a concentration of 1´10 6 cells per dish with DMEM/F-12 with 1% FBS. After overnight incubation, the culture medium was replaced with new complete medium and then treated with sericin at a concentration of 1600 mg/ml for 72 h. After treatment, the cells were harvested by trypsinization, washed with PBS pH 7.4, and fi xed in 70% ethanol at 4 °C for 1 h. The cells were then treated with 100 mg/ml of RNase A at 37 °C for 30 min and then stained with 20 mg/ml of PI (Molecular Probes, Invitrogen, NY, USA) for 30 min at room temperature in the dark. The cell analysis was performed by FACSCalibur using CellQuestPro software (Becton Dickinson).
Statistical analysis
All data was expressed as mean ± standard deviation (SD). The statistical analysis was performed by using a one-way analysis of variance (ANOVA) and a two-tailed Student's t-test. The p values < 0.05 were considered statistically signifi cant.
RESULTS
Effect of sericin on SW480 and FHC cell viability
SW480 colon cancer cells and FHC normal colon cells were treated with small or large sericin at various concentrations (25-1,600 mg/ml) for 24, 48 and 72 h. Both sizes of sericin at all tested concentrations did not affect the viability of either type of cell at treatment periods of 24 and 48 h (data not shown). At 72 h of sericin treatment, the viability of SW480 and FHC cells gradually decreased with an increasing concentration of sericin (Figure 1 ). These fi ndings suggest that sericin has considerably low cytotoxicity to both colon cancer cells and normal colon cells. To compare between small and large sericin, the small sericin has a slightly higher anti-proliferative effect than that of the large sericin (Table 1) . Large sericin seemed to reduce the viability of colonic adenocarcinoma SW480 better than normal FHC cells ( Figure 1A ), whereas small sericin did not show such differences ( Figure 1B) . The results suggest that sericin possesses low to moderate effect on the cellular viability for colon cells.
Effect of sericin on SW480 and FHC cell apoptosis
At 72 h of treatment, sericin at 1,600 mg/ml showed a signifi cant reduction of SW480 and FHC cell viability. These cells were then tested as to whether they underwent cell apoptosis or necrosis. The result showed that small but not large sericin signifi cantly increased the percentage of late apoptotic cells in adenocarcinoma SW480 cells (Figure 2A ). Neither size of sericin changed the percentage of necrotic cells when compared to the control cells and PBS-treated cells (Figure 2A ). In contrast, the colonic normal FHC cells did not undergo cell death either via apoptotic or necrotic processes following sericin treatment ( Figure 2B ).
Effect of sericin on caspase-3 activity
Caspase-3 is an executioner caspase, whose activity is increased when cells are about to undergo apoptosis. Therefore, we determined whether or not caspase-3 activity was directly involved in cell apoptosis induced by sericin. As shown in Figure 3 , SW480 cells treated with sericin at 1,600 mg/ml for 72 h exhibited increased caspase-3 activity. Only the small sericin significantly enhanced caspase-3 activity in SW480 cells. This suggests that sericin, particularly the small-sized, induced adenocarcinoma colonic cells to undergo apoptosis through a caspase-3 dependent pathway.
Effect of sericin on Bcl-2 and Bax expression
The expression of anti-apoptotic protein Bcl-2 and proapoptotic protein Bax were also expected to correlate with the degree of apoptosis of SW480 cells in the previous experiment. The expression of these proteins was examined by using Western blotting. After treating the cells with both sizes of sericin at 1,600 mg/ml for 72 h, there was a slight reduction of Bcl-2 protein levels, but only the small sericin showed a significant effect (Figure 4 ). The expression of the Bax protein in sericin-treated cells did not differ from that in the control cells (Figure 4 ). This suggests that sericin down-regulated anti-apoptotic protein Bcl-2, which may then enhance adenocarcinoma SW480 cells to undergo an apoptotic process.
Effec t of sericin on the cell cycle
To further investigate whether or not the inhibitory effect of sericin on SW480 cell viability might partially be due to an arrest of cell proliferation, a cell cycle analysis was also conducted by using fl ow cytometry. After treating the SW480 cells with sericin at 1,600 mg/ml for 72 h, they were harvested and stained with PI. As shown in Table 2 , the colon adenocarcinoma SW480 cells had a higher percentage of cells in the S phase (19.22±6.33%) than FHC normal colonic cells (7.64±1.01). After treatment with either small or large sericin, the percentage of SW480 cells in the S phase fell below the control level, although the reductions were not statistically significant. Interestingly, both sizes of sericin caused a signifi cant increase in the percentage of the S-phase of FHC cells as compared to the control cells. These results suggest that the cell cycle of adenocarcinoma and normal colonic cell lines are differently regulated by sericin treatment.
DISCUSSION
Sericin has previously been reported to suppress colon tumorigenesis in animal models (Zhaorigetu et al., 2001; Zhaorigetu et al., 2007) . However, there is still a limited number of studies that explain sericin's mechanisms of action for this process. Thus, this present study investigated whether sericin has any effects on colon cancer cells and normal colonic cells. The results showed that sericin exerted a greater inhibitory effect on SW480 cells than on FHC cells. Sericin also exerted a moderate inhibitory effect on the cell viability of SW480 and FHC cells. Small-size sericin (61-132 kDa) reduced the viability of SW480 cells via the induction of cell apoptosis as well as by the reduction of the S-phase cell population. Large-size sericin (191-339 kDa) seems to decrease SW480 cell viability through cell cycle regulation. The sericin-induced apoptsis of SW480 cells was associated with an increase in caspase-3 activity and a down-regulation of Bcl-2 antiapoptotic proteins. Normal FHC colonic cells did not undergo apoptosis, and the cell cycle of these cells changed only slightly after the sericin treatment. The observed chemopreventative effect may be attributed to several mechanisms, such as suppression of cancer cell proliferation, induction of cell apoptosis, inhibition of angiogenesis, and regulation of the cancer cell cycle. Among these mechanisms, cell apoptosis is the major target for the treatment and prevention of colon cancer (Lifshitz et al., 2001; Sun et al., 2004; Huerta et al., 2006) . In the present study, sericin induced late apoptosis in SW480 colon cancer cells but not in FHC normal colonic cells. Early apoptosis is characterized by the changes in the cellular membrane. Phosphatidyl serine, normally located inside the cell membrane, moves to the outer surface, and mitochondrial membrane potential drops. Late apoptosis involves fragmentation of nuclear chromatin. The stages of apoptosis depend on differential apoptotic stimuli, as well as functions of anti-apoptotic and pro-apoptotic proteins (Indran et al., 2011; Kelly et al., 2011; Ascenzi et al., 2011) . Malignant transformation of epithelial cells, including those of the colon, also involves various proteins that promote or inhibit apoptosis at different stages (Royer and Lu, 2011) . Thus, it is possible that sericin might have an infl uence on some as yet unidentifi ed proteins associated with the late apoptotic stage in colon cancer cells. The mechanisms of apoptosis mainly involve two signaling pathways, namely the intrinsic pathway, involving the activation of the mitochondria and several caspases, and the extrinsic pathway, involving the activation of death receptors (Elmore, 2007) . The key element in a mitochondrial pathway is the release of cytochrome c from mitochondria to cytosol to bind to Apaf-1 and caspase-9, and fi nally to activate caspase-3 (Shi, 2002). Caspase-3 activity is increased when the cells undergo apoptosis (Stennicke and Salvesen, 1998; Wang et al., 2005) . In addition to caspase-3, apoptosis regulatory proteins Bcl-2 and Bax associated with the mitochondrial pathway were also examined. In sericin treated SW480 cells, Bcl-2 was down-regulated, but Bax remained unchanged. These fi ndings suggest that sericin may promote cell apoptosis via the mitochondrial pathway. However, the reduced viability of FHC normal cells induced by sericin was not associated with cell apoptosis. However, the decrease in cell viability after the sericin treatment might have been a result of mechanisms other than apoptosis such as cell cycle regulation.
Cell cycle is a complex process involved in cellular proliferation. A defect in the normal pattern of cell cycle may lead to excessive proliferation and fi nally to the formation of cancerous cells (Schafer, 1998) . Although the present fi ndings showed that sericin had no signifi cant effect on the cell cycle of SW480 cells, the percentage of cells in the G0/G1 phase tended to increase. Interestingly, the cell cycle of FHC cells was arrested at the S phase, indicating that sericin, at least in part, may accelerate cell proliferation in normal colonic cells.
Since sericin is a polymeric protein, different extraction techniques can produce different sizes of sericin. Biological activities of sericin are associated with its molecular weight. Small-size sericin (5-100 kDa) rather than large-size sericin (50-200 kDa) can accelerate the proliferation of hybridoma cells (Terada, 2005) . The present results showed that small-size sericin (61-132 kDa), but not large-size sericin (191-339 kDa), signifi cantly reduced cell viability and induced cell apoptosis in SW480 cell. In conclusion, the present study demonstrates that a small sericin of 61-132 kDa has anti-proliferative effects for SW480 human colon carcinoma cells. Sericin could induce cell apoptosis associated with an increase in caspase-3 activity and a decrease in Bcl-2 anti-apoptotic protein expression. Sericin had no cytotoxicity, and indeed it might accelerate cell proliferation of FHC normal colonic cells. Thus, sericin appeared to exert a chemopreventive effect against colon cancer by inducing apoptosis in cancerous cells, whereas this protein had no effect on normal colonic cells. Therefore, sericin may have signifi cant health benefi ts and it could potentially be developed as a dietary supplement for colon cancer prevention.
